by Asa Elmore | Apr 20, 2021 | News, Press Releases
Sutro Biopharma Promotes Trevor Hallam, Ph.D., to President of Research and Chief Scientific Officer SOUTH SAN FRANCISCO, Calif., April 20, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on...
by Asa Elmore | Apr 15, 2021 | News, Press Releases
Sutro Biopharma Earns Milestone Payment from Cytokine Derivatives Collaboration with Merck – Initiation of an IND enabling toxicology study for the first program under the 2018 collaboration oncytokine derivatives earns a $15 million milestone payment from Merck...
by Asa Elmore | Apr 8, 2021 | Events, News, Presentations, Press Releases
Sutro Biopharma to Present at Two Upcoming Investor Conferences SOUTH SAN FRANCISCO, Calif., April 8, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein...
by Asa Elmore | Mar 22, 2021 | News, Press Releases
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board SOUTH SAN FRANCISCO, Calif., March. 22, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company...
by Asa Elmore | Mar 18, 2021 | News, Press Releases
Sutro Biopharma Reports Full Year 2020 Financial Results and Provides Business Highlights and 2021 Anticipated Milestones – Year-end 2020 cash, cash equivalents and marketable securities of $326.5 million, with projected runway into the second half of 2023...
by Asa Elmore | Feb 23, 2021 | Events, News, Press Releases
Sutro Biopharma to Participate in the Cowen 41st Annual Healthcare Conference SOUTH SAN FRANCISCO, Calif., Feb. 23, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of...
